4//SEC Filing
Serber Zachariah 4
Accession 0001645842-22-000015
CIK 0001645842other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 6:54 PM ET
Size
7.1 KB
Accession
0001645842-22-000015
Insider Transaction Report
Form 4
Serber Zachariah
DirectorChief Science Officer
Transactions
- Sale
Common Stock
2022-02-07$4.33/sh−5,435$23,529→ 2,380,350 total
Holdings
- 40,000(indirect: See Footnote)
Common Stock
- 40,000(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2021 that provides for the sale of up to 250,000 shares over the next ten (10) months, which started January 24, 2022.
- [F2]Transaction executed in multiple trades at prices ranging from $4.24 to $4.57 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Held by the Rorik Serber 2021 Irrevocable Trust.
- [F4]Held by spouse as custodian for children under the California Uniform Transfer to Minors Act.
Documents
Issuer
Zymergen Inc.
CIK 0001645842
Entity typeother
Related Parties
1- filerCIK 0001845655
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 6:54 PM ET
- Size
- 7.1 KB